stock-mb-logo-androidstock-mb-logo-ios
Stock Screener App
Free - Play StoreApp Store
InstallInstall
logo
Celldex Therapeutics IncCLDX
$27.961.49%0.41

Celldex Therapeutics Inc (CLDX)

Celldex Therapeutics Inc stock is traded at $27.96, with a volume of 751,760. It is up +1.49% in the last 24 hours and down -7.69% over the past month. Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, and other mast cell-mediated diseases. The company operates in a single operating and reportable segment in the business of development, manufacturing and commercialization of novel therapeutics for human health care.
Previous Close:
$27.55
Open:
$27.82
24h Volume:
751,760
Relative Volume:
0.92
Market Cap:
$2.20B
Revenue:
$866.00K
Net Income/Loss:
-$283.65M
P/E Ratio:
-
EPS:
-$4.27
Net Cash Flow:
-$226.25M
1W Performance:
-3.02%
1M Performance:
-7.69%
6M Performance:
-9.51%
1Y Performance:
+11.53%
1-Day Range:
$27.16$28.54
1-Week Range:
$27.16$29.31
52-Week Range:
$22.33$45.14

Celldex Therapeutics Inc Stock (CLDX) Company Profile

Name
Celldex Therapeutics Inc
Phone
908-200-7500
Address
53 FRONTAGE ROAD, HAMPTON, USA
Employee
198
Next Earnings Date
-
Latest SEC Filings
SEC
CLDX's Discussions on X
X

 

Market Cap

 

Revenue

 

Net Income

 

Cash Flow

 

EPS

 

Celldex Therapeutics Inc Stock (CLDX) Financials Data

Similar to CLDX